Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-06

Clinical Trial Update: Progression of Disease in Patients Newly Diagnosed With Glaucoma and Glaucoma Suspects Participating in the GATE Study

View source ↗

Summary

The University of Aberdeen-sponsored GATE study tracked progression of glaucoma in patients newly diagnosed with glaucoma and in glaucoma suspects; the trial st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Aberdeen | Conditions: Glaucoma | Status: COMPLETED